Report Overview

The global Type-1 diabetes treatment market size stood at around USD 5.7 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Diabetes is a group of endocrine disorders, typically related to blood sugar. The three types include type 1, type 2, and gestational diabetes. Among these, type 1 diabetes is more common in children and young adults. Treated with a wide range of insulin delivery devices and drugs, type 1 diabetes (T1D) is today one of the most prevalent chronic diseases worldwide. Type-1 diabetes accounts for 5%10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. The onset of the disease may be at a young age or exacerbated by aging and lifestyle, and management requires lifelong medication.



Market Drivers

Rising prevalence of type-1 diabetes due to environmental and genetic factors, growing geriatric population, which is susceptible to type-1 diabetes, increasing prevalence of obesity are contributing factors to the market growth. Rising worldwide spending on healthcare, growing access to medication worldwide, improved diagnostic capabilities ensuring early detection and government support for the treatment of type-1 diabetes also drives the market growth

Type-1 Diabetes Epidemiology

The image shows the incidence of type-1 diabetes in children worldwide.